810223C

C12-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810223C

• Synonym(s): N-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-D-glucosyl-β1-1′-sphingosine
• Empirical Formula (Hill Notation): C₄₂H₇₁N₅O₁₁
• CAS Number: 474943-01-6
• Molecular Weight: 822.04
• UNSPSC Code: 12352211
• NACRES: NA.25

Properties

• Assay: >99% (TLC)
• form: liquid
• packaging: pkg of 1 × 1 mL (810223C-250ug)
• manufacturer/tradename: Avanti Research^™ - A Croda Brand 810223C
• concentration: 0.25 mg/mL (810223C-250ug)
• shipped in: dry ice
• storage temp.: −20°C

Description

Application

C12-NBD Glucosyl Ceramide is suitable for liposome preparation.

Biochem/physiol Actions

Glucosyl ceramide (GlcCer) is produced by GlcCer synthase from ceramide in the cytosolic membranes of Golgi. In the luminal Golgi membrane, GlcCer participates in the generation of glycosphingolipids.

Packaging

5 mL Amber Glass Screw Cap Vial (810223C-250ug)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Safety Information

• Pictograms: GHS06,GHS08
• Signal Word: Danger
• Hazard Statements: H302,H315,H319,H331,H336,H351,H361d,H372
• Precautionary Statements: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• Hazard Classifications: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Target Organs: Central nervous system
• WGK: WGK 3